EVO
Evotec SE ADR
NASDAQ: EVO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$2.94
-1.34% today
Updated 2026-04-29
Market cap
$1.04B
P/E ratio
—
P/S ratio
1.33x
EPS (TTM)
$-0.34
Dividend yield
—
52W range
$2 – $5
Volume
0.1M
Evotec SE ADR (EVO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-13.10%
Operating margin
9.17%
ROE
-11.70%
ROA
-2.28%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $67.35M | $-32.47M | 34.08% | -54.58% | -48.21% |
| 2007 | $32.88M | $-11.16M | 24.40% | -176.72% | -33.92% |
| 2008 | $39.61M | $-78.29M | 44.52% | -184.81% | -197.63% |
| 2009 | $42.68M | $-45.50M | 43.16% | -99.10% | -106.59% |
| 2010 | $55.26M | $3.26M | 44.06% | 3.10% | 5.90% |
| 2011 | $80.13M | $6.75M | 43.66% | 6.50% | 8.42% |
| 2012 | $87.27M | $2.48M | 35.55% | -3.67% | 2.84% |
| 2013 | $85.94M | $-25.43M | 36.33% | -24.84% | -29.59% |
| 2014 | $89.50M | $-6.98M | 32.83% | -7.13% | -7.80% |
| 2015 | $127.68M | $16.52M | 29.75% | 9.12% | 12.94% |
| 2016 | $164.51M | $27.53M | 35.59% | 19.05% | 16.73% |
| 2017 | $257.63M | $24.26M | 32.05% | 14.55% | 9.42% |
| 2018 | $375.40M | $84.17M | 29.84% | 20.63% | 22.42% |
| 2019 | $446.44M | $38.16M | 29.77% | 14.02% | 8.55% |
| 2020 | $500.92M | $6.28M | 25.10% | 9.69% | 1.25% |
| 2021 | $618.03M | $215.51M | 24.52% | 6.63% | 34.87% |
| 2022 | $751.45M | $-175.66M | 23.16% | 2.77% | -23.38% |
| 2023 | $781.43M | $-83.91M | 22.40% | -13.70% | -10.74% |
| 2024 | $796.97M | $-196.08M | 14.41% | -17.88% | -24.60% |
| 2025 | $757.26M | $-99.43M | 8.27% | -17.87% | -13.13% |